N/A
Completed N=91
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
Source: ClinicalTrials.gov NCT04514523 ↗Enrolled (actual)
91
Serious AEs
0.0%
Results posted
Jan 2023
Primary outcomePrimary: Acceptability - Patients — 16; 21; 12; 6 Participants
Summary
The purpose of this study is to co-develop a toolkit (known as the QBSAfe toolkit) with patients, family caregivers, and clinicians that focuses on palliating symptoms, alleviating burden of treatment, facilitating social connections, and optimizing treatment safety for patients with diabetes mellitus.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability - Patients |
16; 21; 12; 6; 3; 12 | — |
| PRIMARY Acceptability - Clinicians |
48; 14; 4; 3; 0; 43 | — |
| SECONDARY Feasibility 1 |
58; 7 | — |
| SECONDARY Feasibility 2 |
58 | — |
| SECONDARY Feasibility 3 |
145 | — |
Eligibility Criteria
Inclusion Criteria
-Existing diagnosis of diabetes mellitus; have an existing appointment with a participating clinician
Exclusion Criteria
- Do not speak English
- Severe vision/hearing impairment
- Unable to give informed consent for any reason
Data sourced from ClinicalTrials.gov (NCT04514523). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.